Area of research
Molecular Biology · Oncology
Research interest
Research interests include Angiogenesis and VEGF in Cancer, Cancer Cells and Metastasis, Radiopharmaceutical Chemistry and Applications, and Cancer, Hypoxia, and Metabolism.
Identification and characterization of tertiary lymphoid structures in brain metastases
RECQL4 affects MHC class II‐mediated signalling and favours an immune‐evasive signature that limits response to immune checkpoint inhibitor therapy in patients with malignant melanoma
Serpins A1/A3 within tumor-derived extracellular vesicles support pro-tumoral bias of neutrophils in cancer
T lymphocyte recruitment to melanoma brain tumors depends on distinct venous vessels
Spatial proteomics reveals sirtuin 1 to be a determinant of T-cell infiltration in human melanoma
Identification and characterization of tertiary lymphoid structures in brain metastases
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
Active Remodeling of Capillary Endothelium via Cancer Cell–Derived MMP9 Promotes Metastatic Brain Colonization
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
Persister state-directed transitioning and vulnerability in melanoma
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
<scp>SIRT1</scp>‐mediated deacetylation of FOXO3a transcription factor supports pro‐angiogenic activity of interferon‐deficient tumor‐associated neutrophils
Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
Persister state-directed transitioning and vulnerability in melanoma
The Janus-faced role of KDM5B heterogeneity in melanoma: differentiation as a situational driver of both growth arrest and drug-resistance
2020cited by 1position: middle
Size Matters: The Functional Role of the CEACAM1 Isoform Signature and Its Impact for NK Cell-Mediated Killing in Melanoma
Targeting the “undruggable” RAS - new strategies - new hope?
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regression
Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging
CEACAM1-3S Drives Melanoma Cells into NK Cell-Mediated Cytolysis and Enhances Patient Survival
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma